Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching New Era in Biologics Development
As Bora Biologics, the organization will continue to build upon its established reputation for quality and excellence in ...
Aims to accelerate the lead candidate’s journey toward clinical success and expand its reach to patients who need it.
Kyverna Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Naji Gehchan, M.D., MBA, as Chief ...
Conduit Pharmaceuticals Inc. has entered into a strategic services agreement with formulation development CDMO Agility Life ...
Evotec SE, together with Yonsei University and the Korean biotech company Zymedi, will receive a $4.5 million grant from the ...
Medix Biochemica, a supplier of critical raw materials for the in vitro diagnostics (IVD) industry, has acquired Candor ...
Nature’s Toolbox (NTx), a life sciences company developing next-gen platforms for RNA and protein manufacturing, announced the full commercial availability of NTxscribe, a benchtop, continuous flow ...
The Syntegon Group has appointed Eros Carletti as new Chief Financial Officer. He joined the company on January 6, 2025. Eros Carletti succeeds Dr. Peter Hackel, who left Syntegon on December 31, 2024 ...
To focus on life sciences as part of an effort to expand its products and services.
Sartorius and McMaster University have opened a new bioprocessing automation lab at the university’s Faculty of Engineering ...
Will further expand Galapagos’ manufacturing network in the U.S. for improved patient experience.
The U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Johnson & Johnson’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback